Nitric oxide and the axonal death cascade

Annals of Neurology

Volumn 53, Issue 2, 2003, Pages 150-153

  Waxman, Stephen G ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SODIUM CALCIUM EXCHANGE PROTEIN; SODIUM CHANNEL;

ALLERGIC ENCEPHALOMYELITIS; AXONAL INJURY; CENTRAL NERVOUS SYSTEM; DEMYELINATION; EDITORIAL; GUILLAIN BARRE SYNDROME; HUMAN; MITOCHONDRIAL RESPIRATION; MULTIPLE SCLEROSIS; NERVE CELL NECROSIS; NERVE FIBER DEGENERATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; WHITE MATTER;

AXONS; CELL DEATH; HUMANS; NERVE DEGENERATION; NITRIC OXIDE;

EID: 0037307981     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10397     Document Type: Editorial

References (32)

1. McDonald WI, Miller DH, Barnes D. The pathological evolution of multiple sclerosis. Neuropatholol Appl Neurobiol 1992;18:319-334.
2. Davie CA, Barker GJ, Webb S, et al. Persistent functional deficit in multiple sclerosis and autosomal dominant cerebellar ataxia is associated with axon loss. Brain 1995;118:1583-1592.
3. Waxman SG. Demyelinating diseases: new pathological insights, new therapeutic targets. N Engl J Med 1998;338: 323-325.
4. Kapoor R, Davies M, Blaker PA, et al. Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann Neurol 2003;53:174-180.
5. 2+ exchanger. J Neurosci 1992;12: 430-439.
6. Stys PK, Ransom BR, Waxman SG. Tertiary and quaternary local anesthetics protect CNS white matter from anoxic injury at concentrations that do not block excitability. J Neurophysiol 1992;67:236-240.
7. Fern R, Ransom BR, Stys PK, Waxman SG. Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam. J Pharmacol Exp Ther 1993;266:1549-1555.
8. Stys PK, Lesiuk H. Correlation between electrophysiological effects of mexiletine and ischemic protection in CNS white matter. J Neurosci 1996;71:27-36.
9. 2+ exchanger. J Neurosci 1996;16:545-552.
10. Teng YD, Wrathall JR. Local blockade of sodium channels by tetrodotoxin ameliorates tissue loss and long-term functional deficits resulting from experimental spinal cord injury. J Neurosci 1997;17:4359-4366.
11. 2+-dependent injury of the dorsal columns. J Neurotrauma 1997;14:299-311.
12. Lo AC, Black JA, Waxman SG. Neuroprotection of axons with phenytoin in experimental allergic encephalomyelitis. Neuroreport 2002;13:1909-1912.
13. Bechtold DA, Kapoor R, Smith KJ. Axonal protection mediated by flecainide therapy in experimental inflammatory demyelinating disease. J Neurol 2002;249(Suppl 1):204.
14. Ferguson B, Matyszak MK, Esiri MM, et al. Axonal damage in acute multiple sclerosis lesions. Brain 1997;120:393-399.
15. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338: 278-285.
16. Bo L, Dawson TM, Wesselingh S, et al. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis. Ann Neurol 1994;36:778-786.
17. Brosnan CF, Battistini L, Raine CS, et al. Reactive nitrogen intermediates in human neuropathology: an overview. Dev Neurosci 1994;16:152-161.
18. Redford CJ, Kapoor R, Smith KJ. Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 1997;120:2149-2157.
19. Shrager P, Custer AW, Kazarinova K, et al. Nerve conduction block by nitric oxide that is mediated by the axonal environment. Brain 1997;120:2149-2157.
20. Kapoor R, Davies M, Smith KJ. Temporary axonal conduction block and axonal loss in inflammatory neurological disease. Ann N Y Acad Sci 2001;893:304-308.
21. Smith KJ, Kapoor R, Hall SM, Davies M. Electrically active axons degenerate when exposed to nitric oxide. Ann Neurol 2001;49:470-476.
22. Garthwaite G, Goodwin DA, Batchelor AM, et al. Nitric oxide toxicity in CNS white matter: an in vitro study using rat optic nerve. Neuroscience 2002;109:145-155.
23. Bitsch A, Schuchardt J, Bunkowski S, et al. Acute axonal injury in multiple sclerosis: correlation with demyelination and inflammation. Brain 2000;123:1174-1183.
24. + conductance in rat optic nerve axons. Proc Natl Acad Sci USA 1993;90:6976-6980.
25. Hammarstrom AK, Gage PW. Nitric oxide increases persistent sodium current in rat hippocampal neurons. J Physiol (Lond) 1999;520:451-461.
26. + channels in C-type DRG neurons by S-nitrosylation. J Neurophysiol 2002;87:761-775.
27. v1.3 sodium channels: rapid repriming and slow closed-state inactivation display quantitative differences following expression in a mammalian cell line and in spinal sensory neurons. J Neurosci 2001;21:5952-5961.
28. Hume AL, Waxman SG. Evoked potentials in suspected multiple sclerosis: diagnostic value and prediction of clinical course. J Neurol Sci 1988;83:191-210.
29. Caldwell JH, Schaller KL, Lasher RS, et al. Sodium channel Nav1.6 is localized at nodes of ranvier, dendrites, and synapses. Proc Natl Acad Sci USA 2000;97:5616-5620.
30. Westenbroek RE, Noebels JL, Catterall WA. Elevated expression of type II Na+ channels in hypomyelinated axons of shiverer mouse brain. J Neurosci 1992;12:2259-2267.
31. Boiko T, Rasband MN, Levinson SR, et al. Compact myelin dictates the differential targeting of two sodium channel isoforms in the same axon. Neuron 2001;30:91-104.
32. Black JA, Dib-Hajj S, Baker D, et al. Sensory neuron specific sodium channel SNS is abnormally expressed in the brains of mice with experimental allergic encephalomyelitis and humans with multiple sclerosis. Proc Natl Acad Sci USA 2000;97:11598-11602.